Product Images Sorilux

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Sorilux NDC 51862-376 by Mayne Pharma, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - sorilux 01

Chemical Structure - sorilux 01

Figure A - sorilux 02

Figure A - sorilux 02

Figure B - sorilux 03

Figure B - sorilux 03

Figure C - sorilux 04

Figure C - sorilux 04

Figure D - sorilux 05

Figure D - sorilux 05

Figure E - sorilux 06

Figure E - sorilux 06

Figure F - sorilux 07

Figure F - sorilux 07

Figure G - sorilux 08

Figure G - sorilux 08

PRINCIPAL DISPLAY PANEL - 60 gram Can Carton - sorilux 09

PRINCIPAL DISPLAY PANEL - 60 gram Can Carton - sorilux 09

Each can of Sorilux Foam contains 60 grams of a medication called calcipotriene. It is intended for topical use only, and should not be applied to the eyes or used orally or intravaginally. Dosage and prescribing information should be obtained from a patient's physician. The can must be shaken prior to use, and users should avoid puncturing or incinerating the container. The foam is flammable, and users should avoid smoking or exposing it to fire or flame. The product should be kept out of reach of children, and should not be stored above 49°C or in direct sunlight. It contains several ingredients, including calcipotriene, cetyl alcohol, and dibasic sodium phosphate. Adverse reactions should be reported to Mayne Pharma or the FDA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.